Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

Glucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably disturbs the normal...

Full description

Bibliographic Details
Main Authors: Rongrong Han, Jing Liang, Bing Zhou
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/11/5887
_version_ 1797531953278222336
author Rongrong Han
Jing Liang
Bing Zhou
author_facet Rongrong Han
Jing Liang
Bing Zhou
author_sort Rongrong Han
collection DOAJ
description Glucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably disturbs the normal functioning of neurons, which is widely observed in neurodegenerative disease. Understanding the mechanisms of metabolic adaptation during disease progression has become a major focus of research, and interventions in these processes may relieve the neurons from degenerative stress. In this review, we highlight evidence of mitochondrial dysfunction, decreased glucose uptake, and diminished glucose metabolism in different neurodegeneration models such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). We also discuss how hypoxia, a metabolic reprogramming strategy linked to glucose metabolism in tumor cells and normal brain cells, and summarize the evidence for hypoxia as a putative therapy for general neurodegenerative disease.
first_indexed 2024-03-10T10:52:09Z
format Article
id doaj.art-e09ad5c6040e49c186754fcb46d9cae0
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T10:52:09Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-e09ad5c6040e49c186754fcb46d9cae02023-11-21T22:09:08ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-05-012211588710.3390/ijms22115887Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic ReprogrammingRongrong Han0Jing Liang1Bing Zhou2Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of Medicine and Engineering, Beihang University, Beijing 100191, ChinaBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of Medicine and Engineering, Beihang University, Beijing 100191, ChinaBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of Medicine and Engineering, Beihang University, Beijing 100191, ChinaGlucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably disturbs the normal functioning of neurons, which is widely observed in neurodegenerative disease. Understanding the mechanisms of metabolic adaptation during disease progression has become a major focus of research, and interventions in these processes may relieve the neurons from degenerative stress. In this review, we highlight evidence of mitochondrial dysfunction, decreased glucose uptake, and diminished glucose metabolism in different neurodegeneration models such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). We also discuss how hypoxia, a metabolic reprogramming strategy linked to glucose metabolism in tumor cells and normal brain cells, and summarize the evidence for hypoxia as a putative therapy for general neurodegenerative disease.https://www.mdpi.com/1422-0067/22/11/5887brain energy metabolismglucoseneurodegenerative diseasehypoxiametabolic reprogramming
spellingShingle Rongrong Han
Jing Liang
Bing Zhou
Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
International Journal of Molecular Sciences
brain energy metabolism
glucose
neurodegenerative disease
hypoxia
metabolic reprogramming
title Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
title_full Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
title_fullStr Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
title_full_unstemmed Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
title_short Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
title_sort glucose metabolic dysfunction in neurodegenerative diseases new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming
topic brain energy metabolism
glucose
neurodegenerative disease
hypoxia
metabolic reprogramming
url https://www.mdpi.com/1422-0067/22/11/5887
work_keys_str_mv AT rongronghan glucosemetabolicdysfunctioninneurodegenerativediseasesnewmechanisticinsightsandthepotentialofhypoxiaasaprospectivetherapytargetingmetabolicreprogramming
AT jingliang glucosemetabolicdysfunctioninneurodegenerativediseasesnewmechanisticinsightsandthepotentialofhypoxiaasaprospectivetherapytargetingmetabolicreprogramming
AT bingzhou glucosemetabolicdysfunctioninneurodegenerativediseasesnewmechanisticinsightsandthepotentialofhypoxiaasaprospectivetherapytargetingmetabolicreprogramming